Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Tryptamine Therapeutics ( (AU:TYP) ).
Tryptamine Therapeutics Limited has announced an update related to the proposed issue of securities, adjusting the date of the Extraordinary General Meeting (EGM) and the subsequent proposed issue date. This update reflects a significant procedural adjustment, which may affect the company’s financial planning and stakeholder expectations.
More about Tryptamine Therapeutics
YTD Price Performance: 7.89%
Average Trading Volume: 1,842,510
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$52.33M
Learn more about TYP stock on TipRanks’ Stock Analysis page.